newsfilter
← Latest News
Business Wire·

enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

enGene Holdings Inc. (NASDAQ:ENGN), a clinical-stage, non-viral genetic medicines company, today announced that Ron Cooper, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim